Trial Profile
Treatment of Post-TBI Depression.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Nov 2015
Price :
$35
*
At a glance
- Drugs Sertraline (Primary)
- Indications Depression; Major depressive disorder
- Focus Therapeutic Use
- 07 Mar 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 01 May 2009 Primary endpoint 'Hamilton Depression Rating Scale' has not been met.
- 18 Oct 2007 Status changed from recruiting to completed.